1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
- 2019
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
- 2011
-
Mark
Long term risk of infections in Hodgkin lymphoma long-term survivors.
(
- Contribution to journal › Letter
- 2010
-
Mark
Polymorphisms in the Transforming Growth Factor Beta 1 Pathway in Relation to Colorectal Cancer Progression
(
- Contribution to journal › Article
- 2009
-
Mark
Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors-Retrospective cohort analyses and a concept for prospective intervention
(
- Contribution to journal › Article
-
Mark
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis
(
- Contribution to journal › Article
- 2008
-
Mark
Breast cancer survival is associated with telomere length in peripheral blood cells
(
- Contribution to journal › Article